Pharma Pulse 9/10/24: How Satellite Sites Are Outpacing Decentralized Models, Large Numbers of People Clinically Eligible for GLP-1 Drugs & more

Revolutionizing Clinical Trials: How Satellite Sites Are Outpacing Decentralized Models for Faster, More Inclusive Research

Improving accessibility drives faster and more efficient patient enrollment and a more diverse trial population.

KFF: Large Numbers of People Clinically Eligible for GLP-1 Drugs

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on currently approved FDA indications, including 36.2 million people with obesity.

A.I. Isn’t Magic, but Can It Be ‘Agentic’?

So-called agentic artificial intelligence doesn’t require a human to tell it what to do. At least, that’s the idea.

Battelle Awarded U.S. Department of Defense Contract to Develop an Improved Nerve Agent Countermeasure

Battelle and subcontractor CMC Pharmaceuticals announced their selection by the U.S. Department of Defense (DOD) to develop an improved nerve agent countermeasure to enhance the current standard of care for the warfighter and increase survivability. The contract, awarded through the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), funds the development of the medical countermeasure through FDA approval and is valued at over $53 million over 6.5 years.

Jeffrey Bernstein on LinkedIn

The healthcare industry is plagued by cyberattacks including several that recently targeted the blood supply chain triggering emergency protocols at hundreds of hospitals. I discussed these threats along with protection strategies in an interview with Pharmaceutical Executive magazine. Please take a look and IM me to learn more about how Kaufman Rossin is helping clients to plan for and respond to these exploits,https://lnkd.in/ejp8vr8X
#cybersecurity #healthcare #dataprivacy #hipaa #kaufmanrossin

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs